
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Pricing & Access· May 27, 2026 · 11 min read

Biosimilars· May 27, 2026 · 11 min read
Lantus biosimilars and insulin glargine interchangeability guide

Pricing & Access· May 27, 2026 · 11 min read
Leqembi vs Kisunla access guide for anti-amyloid mAb coverage

Policy· May 27, 2026 · 12 min read
Medicare Transaction Facilitator guide for manufacturers

Biosimilars· May 27, 2026 · 12 min read
Neulasta biosimilars coding and reimbursement guide
By Ran Chen#Biosimilars#HCPCS Coding#Oncology

Pricing & Access· May 27, 2026 · 10 min read
Ocrevus vs Ocrevus Zunovo access guide

Pricing & Access· May 27, 2026 · 10 min read
Opdivo Qvantig vs IV Opdivo access guide
By Ran Chen#Oncology#Prior Authorization#Payer Policy

Pricing & Access· May 27, 2026 · 9 min read
Padcev plus Keytruda urothelial cancer access guide

Pricing & Access· May 27, 2026 · 12 min read
Prolia and Xgeva denosumab biosimilars guide
By Ran Chen#Biosimilars#Payer Policy#HCPCS Coding

Pricing & Access· May 27, 2026 · 9 min read
Taltz prior authorization guide for ixekizumab access
By Ran Chen#Immunology#Prior Authorization#Payer Policy